2687-0940Challenges in modern medicine2687-094010.18413/2687-0940-2020-43-2-322-32733SURGERY<strong>FEATURES OF URINE MICROFLORA IN PATIENTS WITH UROLITHIASIS COMPLICATED WITH PYELONEPHRITE</strong><strong>FEATURES OF URINE MICROFLORA IN PATIENTS WITH UROLITHIASIS COMPLICATED WITH PYELONEPHRITE</strong>BerezhnoiA. G.BerezhnoiA. G.DunaevskayaS. S.DunaevskayaS. S.BerezhnayaM. A.BerezhnayaM. A.MamontovA. O.MamontovA. O.202043200

Monitoring the state of urine microflora in patients with urolithiasis, complicated by the development of inflammatory complications, allows timely initiation and rational administration of antibacterial therapy in the conditions of a specific hospital. The aim of the study is to determine the peculiarities of urine microflora composition in patients with urolithiasis complicated by pyelonephrite. 174 patients with urolithiasis were examined, which were divided into two clinical groups: group I (93 patients) &ndash; with undisturbed postoperative course, group II (81 patients) &ndash; with complicated pyelonephrite with postoperative course. The monitoring made it possible to establish the spectrum of leading agents of this complication. Gram-negative flora was found to be more commonly present in the microbial urine spectrum in urolysis patients. The main agent found in crops was Escherichia coli, more commonly sown in patients with complicated disease course.

Monitoring the state of urine microflora in patients with urolithiasis, complicated by the development of inflammatory complications, allows timely initiation and rational administration of antibacterial therapy in the conditions of a specific hospital. The aim of the study is to determine the peculiarities of urine microflora composition in patients with urolithiasis complicated by pyelonephrite. 174 patients with urolithiasis were examined, which were divided into two clinical groups: group I (93 patients) &ndash; with undisturbed postoperative course, group II (81 patients) &ndash; with complicated pyelonephrite with postoperative course. The monitoring made it possible to establish the spectrum of leading agents of this complication. Gram-negative flora was found to be more commonly present in the microbial urine spectrum in urolysis patients. The main agent found in crops was Escherichia coli, more commonly sown in patients with complicated disease course.

urolytispyelonephritisurine microfloraurolytispyelonephritisurine microfloraСписок литературыAkilov F.A. Mukhtarov Sh.T., Giyasov Sh.I., Mirkhamidov D.H., Nasirov F.R., Muratova N.B. 2013. Posleoperatsionnye infektsionno-vospalitel&#39;nye oslozhneniya endoskopicheskikh operatsiy po povodu urolitiaza [Postoperative infectious-inflammatory complications of endoscopic operations for urolytiasis]. Urologiya. 1: 89&ndash;91.Al-Gabri A., Shein I.A. 2003. Ratsional&#39;naya antibiotikoterapiya pri mochekamennoy bolezni [Rational antibiotic therapy in urolithiasis]. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta, 2 (2): 50&ndash;54.Belay S.I., Dovbysh M.A., Belay I.M. 2016. Mochekamennaya bolezn&#39;: aktual&#39;nost&#39; voprosa i perspektivy ego razvitiya [Urolithiasis: relevance of the issue and prospects for its development]. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta, 5 (15): 19&ndash;26.Berezhnoi A.G., Vinnik Yu.S., Dunaevskaya S.S., Antyfrieva D.A. 2019. Vozmozhnosti prognozirovaniya razvitiya vospalitel&#39;nykh oslozhneniy posleoperatsionnogo perioda u bol&#39;nykh s mochekamennoy bolezn&#39;yu [Possibilities of prediction of development of inflammatory complications of postoperative period in patients with urolithiasis]. Vestnik novykh meditsinskikh tekhnologiy. Elektronnoe izdanie, 2: 109&ndash;113.Grigor&#39;ev N.A., Semenyakin I.V., Malkhasyan V.A. 2016. Mochekamennaya bolezn&#39; [Urolithiasis]. Urologiya, S 2: 37&ndash;69.Demin N.V. 2008. Mochekamennaya bolezn&#39;: osnovnye printsipy lecheniya [Urolithiasis: basic principles of treatment]. RMZh, 5 (16): 353&ndash;356.Dutov V.V., Buymister S.Y., Rusanov E.V. 2018. Izmenenie mikroflory mochi u patsientov s mochekamennoy bolezn&#39;yu [Changes in urine microflora in patients with urolithiasis]. Urologiya, 6: 32&ndash;36.Zhurunova M.S., Dautova M.B. 2016. Mochekamennaya bolezn&#39; [Urolithic disease]. Mezhdunarodnyy zhurnal prikladnykh i fundamental&#39;nykh issledovaniy, 6&ndash;5: 977.Malhasyan V.A., Semenyakin I.V., Ivanov V.J., Suhih S.O., Gadjiev N.K. 2018. Obzor oslozhneniy perkutannoy nefrolitotomii i metodov ikh lecheniya [Review of complications of percutaneous nephrolitotomy and methods of their treatment]. Urologiya, 4: 147&ndash;153.Podoynitsyn A.A., Zulkarnayev A.B., Rusanov E.V. 2014. Osobennosti spektra i rezistentnosti k antibiotikam mikroflory u bol&#39;nykh posle litotripsii [Features of spectrum and antibiotic resistance of microflora in patients after lithotripsy]. Al&#39;manakh klinicheskoy meditsiny, 30: 52&ndash;56.Bartges J.W., Callens A.J. 2015. Urolithiasis. Vet. Clin. North. Am. Small. Anim. Pract., 45 (4): 747&ndash;68.Fisang C., Anding R., M&uuml;ller S.C. 2015. Urolithiasis an interdisciplinary diagnostic, thera-peutic and secondary preventive challenge. Dtsch. Arztebl. Int., 112 (6): 83&ndash;91.Hogberg L.D, Weist K., Suetens C., Griskeviciene J. 2014. ECDC publishes a directory of online resources for prevention and control of antimicrobial resistance and healthcare-associated infec-tions. Euro. Surveill., 19 (26): 20847.Marschang S., Bernardo G. 2015. Prevention and control of healthcare associated infection in Europe: a review of patients&lsquo; perspectives and existing differences. J. Hosp. Infect., 89 (4): 357&ndash;62.Nicolle L.E. 2002. Urinary tract in geriatric and institutionalized patients. Current Opinion in Urology, 12 (1): 51&ndash;5.